Heilmittelwerbegesetz: How to Review Health Advertising for German Healthcare Marketing Law

The Heilmittelwerbegesetz (HWG) — Germany's Medicinal Products Advertising Act — is one of the most restrictive health advertising laws in the world. Enacted in 1965 and regularly updated, the HWG governs the advertising of medicinal products, medical devices, therapeutic procedures, and other health-related products and services. Together with the Gesetz gegen den unlauteren Wettbewerb (UWG, Unfair Competition Act) and EU pharmaceutical advertising directives, the HWG creates a framework where virtually every health-related marketing claim is subject to legal scrutiny.

German courts actively enforce the HWG through competitor lawsuits (Abmahnungen), injunctions, and monetary penalties. The Wettbewerbszentrale (Centre for Protection against Unfair Competition) and industry associations regularly bring actions against health advertisers who violate HWG provisions. For pharmaceutical companies, medical device manufacturers, healthcare providers, and health supplement brands, the content of every advertisement must be reviewed against HWG requirements before publication.

The HWG Framework

Key Provisions

The Section 11 Prohibitions

Section 11 of the HWG is particularly detailed, prohibiting health advertising that:

1. Refers to specific disease case histories in a misleading manner
2. Uses expert recommendations in a misleading way
3. Suggests that health can only be maintained through the advertised product
4. Presents the product as equivalent or superior to another treatment without substantiation
5. Uses fear-inducing representations of disease or health conditions
6. Targets children under 14 with health product advertising
7. Uses before-and-after comparisons for certain product categories
8. References scientific studies without accurate representation of methodology and results

Common HWG Compliance Issues

1. Pharmaceutical Advertising

The distinction between prescription (Rx) and over-the-counter (OTC) advertising is fundamental:

Prescription drugs:

• Public-facing advertising is strictly prohibited
• Only professional-directed advertising is permitted
• Disease awareness campaigns must not implicitly promote a specific prescription product
• Patient information must follow approved labeling

OTC drugs (Section 4 requirements):

• Name and composition of the medicinal product
• Areas of application (indications)
• Mandatory risk information: "Zu Risiken und Nebenwirkungen lesen Sie die Packungsbeilage und fragen Sie Ihren Arzt oder Apotheker" (For risks and side effects, read the package insert and ask your doctor or pharmacist)
• This standard phrase is mandatory in every public OTC advertisement

2. Medical Device Advertising

Medical device advertising must:

• Reference only the CE-marked intended use
• Not claim efficacy beyond the certified purpose
• Include risk disclosures appropriate to the device classification
• Not use patient testimonials that suggest guaranteed outcomes
• Comply with MDR (Medical Device Regulation) advertising provisions

3. Health Supplement and Wellness Advertising

Health supplements (Nahrungserganzungsmittel) are not medicinal products under German law, but their advertising is still regulated:

• Cannot claim to prevent, treat, or cure disease (this would reclassify them as medicinal products)
• Health claims must be authorized under the EU Health Claims Regulation (EC 1924/2006)
• "Superfood" and similar marketing terms must not imply medicinal properties
• Traditional herbal products must use approved traditional use claims only

4. Healthcare Provider Advertising

Doctors, dentists, and other healthcare professionals in Germany face additional advertising restrictions:

• The Berufsordnung (professional code of conduct) limits permissible advertising content
• Comparative advertising with other practitioners is restricted
• Claims of specialization must match recognized qualifications
• Pricing transparency requirements apply to aesthetic and elective procedures

A Health Advertising Content Review Checklist

• Product classification is correct (Rx, OTC, medical device, supplement)
• No public advertising for prescription-only products
• OTC advertisements include the mandatory "Zu Risiken und Nebenwirkungen" phrase
• Claims match the approved product label or CE-marked intended use
• Health claims are authorized under EU Health Claims Regulation
• No disease treatment or cure claims for supplements
• Scientific studies cited are accurately represented with methodology
• No prohibited before-and-after images (per Section 10)
• No fear-inducing disease representations (per Section 11)
• No targeting of children under 14 with health product advertising
• Expert recommendations are not used in a misleading manner
• Healthcare provider advertising complies with Berufsordnung
• German-language content is legally accurate and uses correct medical terminology
• No gifts or incentives offered in connection with health products (per Section 7)

Building a Health Advertising Review Process

Organizations marketing health products in Germany should implement:

1. Product classification: Determine the regulatory category and applicable HWG provisions
2. Claim verification: Ensure all health claims are substantiated and authorized
3. Pre-publication compliance review: AI-assisted scanning for HWG violations including missing mandatory phrases, prohibited claims, and Section 11 issues
4. Legal review: German healthcare law review for higher-risk content
5. Post-publication monitoring: Monitor for Abmahnungen (warning letters) and competitor challenges

TeamBench enables healthcare and consumer health organizations to build HWG-specific content reviewers that evaluate health advertising against German regulatory standards. Custom criteria can check mandatory phrase inclusion, claim permissibility, Section 11 compliance, and product classification accuracy — catching violations before they trigger competitor lawsuits or regulatory action.

In Germany's litigious health advertising environment, where competitors actively enforce HWG compliance through the courts, systematic content review is not optional — it is a business necessity.